Description:
Southwest Oncology Group S0941 Registration Worksheet Form Sorafenib Tosylate and Erlotinib Hydrochloride in Treating Patients With Locally Advanced, Unresectable, or Metastatic Gallbladder Cancer or Cholangiocarcinoma Source Form: NCI FormBuilder: https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8229FCFE-E5C8-63E1-E040-BB89AD43798D
Link:
https://formbuilder.nci.nih.gov/FormBuilder/formDetailsAction.do?method=getFormDetails&formIdSeq=8229FCFE-E5C8-63E1-E040-BB89AD43798D
Keywords:
Versions (2) ▾
- 9/19/12
- 1/9/15
Uploaded on:
January 9, 2015
DOI:
No DOI assigned. To request one please log in.License:
Creative Commons BY-NC 3.0 LegacyModel comments:
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for:
Item comments for:
In order to download data models you must be logged in. Please log in or register for free.
Extrahepatic Bile Duct Cancer NCT01093222 Registration - Southwest Oncology Group S0941 Registration Worksheet Form - 3028434v1.0
INSTRUCTIONS: All of the information on this Registration Worksheet and the Protocol Eligibility Section must be answered appropriately for a patient to be considered eligible for registration. This Registration Worksheet must be entirely filled out and referred to during the registration. Do NOT submit this worksheet as part of the patient data.
- StudyEvent: Southwest Oncology Group S0941 Registration Worksheet Form